Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
Completed · Phase 2
Conditions studied: Cocaine-Related Disorders, Substance-Related Disorders
In brief
The purpose of this study is to evaluate the safety and efficacy of flupenthixol and haloperidol for cocaine dependence in individuals with schizophrenia/schizoaffective illness.
Key facts
- Study ID
- NCT00000274
- Run by
- National Institute on Drug Abuse (NIDA)
- People needed
- 60
- Starts
- 1997-03-01
- Expected to finish
- 1999-05-01
- Last updated by the study team
- 2017-01-12
Who can join
Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.
Where it is running
- New York State Psychiatric Institute — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.